0000000000123762

AUTHOR

José Luis Llisterri

showing 12 related works from this author

Additional file 1 of Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant …

2021

Additional file 1.

Data_FILES
researchProduct

Gender differences related to the presence of atrial fibrillation in older hypertensive patients

2013

AIM: To determine whether there are gender differences in the epidemiological profile of atrial fibrillation (AF) and to characterise the clinical, biochemical, and therapeutic factors associated with AF. METHODS: Each investigator (primary care physicians or physicians based in hospital units for hypertension treatment) recruited the first 3 patients with an age of ≥ 65 years and a clinical diagnosis of hypertension (ambulatory blood pressure monitoring and an electrocardiogram, were performed) on the first working day of the week for 5 wk and identified those individuals with atrial fibrillation. A binary logistic regression was performed, including all of the variables that were signific…

medicine.medical_specialtyUnivariate analysisPediatricsAmbulatory blood pressureBrief ArticleHeart diseaseMedicinabusiness.industryAtrial fibrillationmacromolecular substancesmedicine.diseaseAnginaInternal medicineDiabetes mellitusEpidemiologymedicineCorMyocardial infarctionCardiology and Cardiovascular MedicinebusinessWorld Journal of Cardiology
researchProduct

Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH…

2018

During the last few years, the number of patients receiving anticoagulant and antiplatelet therapy has increased worldwide. Since this is a chronic treatment, patients receiving it can be expected to need some kind of surgery or intervention during their lifetime that may require treatment discontinuation. The decision to withdraw antithrombotic therapy depends on the patient's thrombotic risk versus hemorrhagic risk. Assessment of both factors will show the precise management of anticoagulant and antiplatelet therapy in these scenarios. The aim of this consensus document, coordinated by the Cardiovascular Thrombosis Working Group of the Spanish Society of Cardiology, and endorsed by most o…

Malemedicine.medical_specialtymedicine.drug_classHemorrhage030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicineFibrinolytic AgentsRisk FactorsThromboembolismIntervention (counseling)Preoperative CareAntithromboticmedicineHumans030212 general & internal medicineIntensive care medicineAgedAged 80 and overThrombotic riskIntraoperative CareDrug Substitutionbusiness.industryAnticoagulantAnticoagulantsGeneral MedicinePerioperativemedicine.diseaseThrombosisDiscontinuationConventional PCIFemaleAntiagregación Anticoagulación Anticoagulation Antiplatelet Antithrombotic Antitrombótico Cirugía SurgerybusinessPlatelet Aggregation InhibitorsRevista Española de Cardiología (English Edition)
researchProduct

Differences in blood pressure control and stroke mortality across Spain: the Prevención de Riesgo de Ictus (PREV-ICTUS) study.

2007

The objective was to assess the stroke risk and prevalence of the cardiovascular risk factors and to analyze their relationship with the specific stroke rates of mortality in each of the autonomic communities of Spain. We conducted a multicenter, cross-sectional study of population >60 years old in Spanish primary care centers. In all of the subjects, clinical, biochemical, and electrocardiographic data were obtained, and the 10-year stroke risk was calculated using the Framingham score. Mortality rates of stroke, age and sex adjusted, were obtained for each of the autonomic communities from the Ministry of Health. A total of 7343 subjects (mean age: 71.6 years, 53.4% women, 34.4% obese…

Malemedicine.medical_specialtyTime FactorsPopulationBlood PressureRisk AssessmentRisk FactorsInternal medicineDiabetes mellitusInternal MedicinemedicinePrevalenceHumanscardiovascular diseasesRisk factoreducationStrokeAntihypertensive AgentsAgededucation.field_of_studyFramingham Risk ScoreVascular diseasebusiness.industryMortality ratemedicine.diseaseSurgeryStrokeBlood pressureCross-Sectional StudiesTreatment OutcomeSpainHypertensionFemaleHypertrophy Left VentricularbusinessHypertension (Dallas, Tex. : 1979)
researchProduct

Prevalencia de sobrepeso y obesidad en población española de 60 años o más y factores relacionados. Estudio PREV-ICTUS

2008

Fundamento y objetivo: Los datos sobre prevalencia de obesidad en poblacion de edad avanzada en Espana son escasos. El objetivo de este trabajo ha sido describir la prevalencia de obesidad y los factores relacionados en una muestra aleatoria de la poblacion espanola de 60 anos o mas, estratificada por comunidades autonomas (CC.AA.). Sujetos y metodo: Se analizo el estudio PREV-ICTUS, realizado en una muestra seleccionada aleatoriamente entre septiembre y diciembre de 2005, estratificada por CC.AA. segun el censo y el habitat de atencion. Se clasifico a los sujetos segun su indice de masa corporal (IMC) en aquellos con peso normal (IMC < 25), sobrepeso (IMC de 25-29,9) y obesos (IMC $ 30). R…

business.industryMedicineGeneral MedicinebusinessHumanitiesMedicina Clínica
researchProduct

Prevalencia de fibrilación auricular en la población española de 60 o más años de edad. Estudio PREV-ICTUS

2007

Introduction and objectives. The aims of this study were to determine the prevalence of atrial fibrillation in individuals aged 60 years or more in Spain using a random sample of the population and to identify associated factors. Methods. An analysis of the PREV-ICTUS study, a randomized cross-sectional population-based study of individuals aged 60 years or more, was carried out. Data on demographic variables, cardiovascular risk factors, and cardiovascular disease were obtained from medical records. The diagnosis of atrial fibrillation was based on the patient’s medical history and an electrocardiogram performed during the study. Results. In the 7108 individuals studied (mean age, 71.9 [7.…

medicine.medical_specialtyeducation.field_of_studyCross-sectional studybusiness.industryPopulationAtrial fibrillationOdds ratiomedicine.diseaseLeft ventricular hypertrophyConfidence intervalBlood pressureInternal medicinemedicineCardiologyMedical historyCardiology and Cardiovascular MedicineeducationbusinessRevista Española de Cardiología
researchProduct

Prevalencia del síndrome metabólico en la población española de 60 años o más. Estudio de base poblacional PREV-ICTUS

2009

Resumen Fundamento y objetivos se dispone de poca informacion sobre el sindrome metabolico (SM) en poblacion de edad avanzada. Los objetivos de este estudio han sido estimar su prevalencia en poblacion general espanola de 60 anos o mas y los factores asociados. Pacientes y metodo se realizo un estudio transversal de ambito poblacional en una muestra aleatoria y representativa de individuos de 60 anos o mas de todo el territorio espanol, estratificada por comunidades autonomas segun censo y habitat de residencia, entre septiembre y diciembre de 2005. Se recogieron datos sociodemograficos, clinicos, bioquimicos y electrocardiograficos. Para la definicion del SM se utilizaron los criterios del…

business.industryMedicineGeneral MedicinebusinessHumanitiesMedicina Clínica
researchProduct

Blood pressure and estimated risk of stroke in the elderly population of Spain: the PREV-ICTUS study.

2007

Background and Purpose— The objective of this study was to estimate the high blood pressure values and the 10-year risk of stroke in the Spanish general population aged 60 years or older using the Framingham scale. Methods— This was a multicenter, population-based, cross-sectional study performed in Spanish primary care centers. A randomized selection of centers and recruitment population was used. We collected clinical, biochemical, and electrocardiographic data. Results— We analyzed 7343 subjects (mean age, 71.6 years; standard deviation, 7.0; 53.4% females, 34.4% obese subjects, and 27.1% diabetic subjects). Electrocardiographic–left ventricle hypertrophy was present in 12.9% of the sub…

Malemedicine.medical_specialtyAgingPopulationBlood PressureComorbidityAge DistributionRisk FactorsElderly populationAtrial FibrillationPrevalenceMedicineHumansRisk factoreducationStrokeAgedAdvanced and Specialized Nursingeducation.field_of_studybusiness.industryVascular diseaseMiddle Agedmedicine.diseaseStrokeBlood pressureCross-Sectional StudiesSpainHypertensionPhysical therapyFemaleHypertrophy Left VentricularNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessDemographyStroke
researchProduct

Prevalencia de fibrilación auricular y uso de fármacos antitrombóticos en el paciente hipertenso ≥ 65 años. El registro FAPRES.

2009

Introduccion y objetivos Entre los principales factores asociados a la presencia de fibrilacion auricular y mayor riesgo embolico estan la edad y la hipertension arterial. Nuestro objetivo es conocer la prevalencia de fibrilacion auricular en el paciente hipertenso de 65 o mas anos de edad en la Comunidad Valenciana y el empleo de farmacos antitromboticos. Metodos Cada investigador incluyo a los primeros 3 pacientes hipertensos de edad ≥ 65 anos que acudian a la consulta el primer dia de la semana durante 5 semanas. Se recogieron los factores de riesgo, la historia cardiovascular, la puntuacion CHADS2 y el tratamiento farmacologico y se realizo un electrocardiograma para su analisis central…

business.industryMedicineCardiology and Cardiovascular MedicinebusinessHumanitiesRevista espanola de cardiologia
researchProduct

Prevalencia de filtrado glomerular disminuido en la población española de edad avanzada. Estudio PREV-ICTUS

2007

Fundamento y objetivo Estimar la prevalencia de filtrado glomerular (FG) disminuido ( Pacientes y metodo Se analizo el estudio PREV-ICTUS, realizado en una muestra de individuos de 60 anos o mas seleccionada aleatoriamente, estratificada por comunidades autonomas segun el censo y el habitat de atencion. Se recogieron datos demograficos, factores de riesgo y enfermedades cardiovasculares. Se calculo el FG utilizando la formula de MDRD (Modification of Diet in Renal Disease). Resultados En 6.799 individuos (edad media 71,9 anos; 53,6% mujeres; 72,9% con hipertension arterial [HTA]; 27,0% con diabetes mellitus [DM]; 24,3% con enfermedad cardiovascular), el 25,9% presento FG disminuido (interva…

Gynecologymedicine.medical_specialtybusiness.industrymedicineGeneral MedicinebusinessMedicina Clínica
researchProduct

Losartan reduces microalbuminuria in hypertensive microalbuminuric type 2 diabetics.

2001

Background. The aim of the present study was to assess the antialbuminuric effect of losartan in a large number of hypertensive type 2 diabetics. Methods. This was a 6-month, open-label, prospective and multicentre study. A total of 422 patients with type 2 diabetes who were hypertensive [sitting systolic blood pressure (SBP) > 140 mmHg and/or diastolic blood pressure (DBP) ≥90 mmHg] and microalbuminuric [urinary albumin excretion (UAE) 30-300 mg/day] were eligible for the study. After a 2-week run-in period, patients were placed on losartan 50 mg once a day. If the BP did not reach the desired goal (<140/90 mmHg) after a 4-week period, the losartan dose was doubled. In the absence of contr…

Blood Glucosemedicine.medical_specialtySystoleUrologyRenal functionBlood PressureType 2 diabetesLosartanDiabetic nephropathyDiastoleDiabetes mellitusInternal medicinemedicineAlbuminuriaHumansAntihypertensive AgentsGlycated HemoglobinTransplantationbusiness.industryBody Weightmedicine.diseaseAngiotensin IIUric AcidLosartanEndocrinologyBlood pressureHydrochlorothiazideDiabetes Mellitus Type 2NephrologyHypertensionRegression AnalysisMicroalbuminuriaDrug Therapy CombinationbusinessDiabetic Angiopathiesmedicine.drugNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
researchProduct

Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney dis…

2021

Background: Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent hereditary renal disease. There is an increased rate of cardiovascular disease (CVD) in ADPKD. In this study, we evaluate the prevalence of cardiovascular risk factors, the achievement rates for treatment goals and cardiovascular events (CVE) in ADPKD and their relations with asymptomatic CVD in CKD from other etiologies (CKDoe) and controls. Methods: We evaluated 2445 CKD patients (2010–2012). The information collected was: clinical, anthropometric and analytical parameters, treatments and CVD evaluation (intima-media thickness (IMT), atheromatous plaque presence and ankle-brachial index (ABI)). Laborator…

MaleNephrologymedicine.medical_specialtyAutosomal dominant polycystic kidney diseaseRenal functionComorbiditylcsh:RC870-923urologic and male genital diseasesCarotid Intima-Media ThicknessAsymptomaticNephropathyAutosomal dominant polycystic kidney diseaseInternal medicineChronic kidney diseasemedicineHumansAnkle Brachial Indexcardiovascular diseasesRenal Insufficiency ChronicProteinuriabusiness.industryMiddle AgedPolycystic Kidney Autosomal DominantPrognosislcsh:Diseases of the genitourinary system. Urologymedicine.diseaseCardiovascular diseasePlaque Atheroscleroticfemale genital diseases and pregnancy complicationsNephropathyCor MalaltiesBlood pressureCardiovascular DiseasesHeart Disease Risk FactorsNephrologyDisease ProgressionInsuficiència renal crònicaFemalemedicine.symptombusinessResearch ArticleKidney disease
researchProduct